Fanila Shahzad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fanila Shahzad has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Mojgan Najafzadeh
School of Life Sciences University of Bradford Bradford UK
2 shared publications - Talat Nasim
Translational Medicine Laboratory, School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford BD7 1DP, UK
2 shared publications Andrew Wright
Bradford Teaching Hospitals NHS Foundation Trust Bradford Royal Infirmary Bradford UK
1 shared publication- Anna L. M. Smith
Newcastle University
1 shared publication - Anwarul Azim Majumder
Bridgetown International University School of Medicine
1 shared publication Badie Jacob
Bradford Teaching Hospitals NHS Foundation Trust Bradford Royal Infirmary Bradford UK
1 shared publication
Latest Publications
- Open Access
The Transcription Factor Sob Maintains Intestinal Stem Cell Homeostasis to Delay Ageing
Ageing is associated with physiological decline and disrupted tissue homeostasis, often driven by imbalanced stem cell activity. The Drosophila midgut serves as a powerful model for studying epithelial homeostasis and ageing as it exhibits many conserved hallmarks of regulation and deteriorating intestinal stem cell function with age. We have identified the transcription factor encoded by Sister of odd and bowl (Sob) as a conserved marker of intestinal stem/progenitor cells in homeostasis whose expression is lost with age. Premature downregulation of sob shortens lifespan while overexpression in the intestinal stem/progenitor cells is sufficient to extend lifespan, suggesting a critical role in maintaining homeostasis with age. At the cell and tissue level stem/progenitor knockdown and overexpression reveal that Sob maintains homeostasis by regulating both proliferation and lineage specification. In young guts, Sob restricts intestinal stem cell proliferation and promotes enteroendocrine differentiation while limiting excessive enterocyte differentiation. We have also found that the transcription factor Exex, the Notch pathway inhibitor Numb, and the enterocyte differentiation regulator Dawdle act downstream of Sob to regulate proliferation and differentiation. Our findings position Sob as a critical molecular switch linking stem cell dysfunction to gut ageing.
Open AccessThe Transcription Factor Sob Maintains Intestinal Stem Cell Homeostasis to Delay Ageing
Ageing is associated with physiological decline and disrupted tissue homeostasis, often driven by imbalanced stem cell activity. The Drosophila midgut serves as a powerful model for studying epithelial homeostasis and ageing as it exhibits many conserved hallmarks of regulation and deteriorating intestinal stem cell function with age. We have identified the transcription factor encoded by Sister of odd and bowl (Sob) as a conserved marker of intestinal stem/progenitor cells in homeostasis whose expression is lost with age. Premature downregulation of sob shortens lifespan while overexpression in the intestinal stem/progenitor cells is sufficient to extend lifespan, suggesting a critical role in maintaining homeostasis with age. At the cell and tissue level stem/progenitor knockdown and overexpression reveal that Sob maintains homeostasis by regulating both proliferation and lineage specification. In young guts, Sob restricts intestinal stem cell proliferation and promotes enteroendocrine differentiation while limiting excessive enterocyte differentiation. We have also found that the transcription factor Exex, the Notch pathway inhibitor Numb, and the enterocyte differentiation regulator Dawdle act downstream of Sob to regulate proliferation and differentiation. Our findings position Sob as a critical molecular switch linking stem cell dysfunction to gut ageing.
- Open Access
The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection
The 2019 novel coronavirus, SARS-CoV-2, producing the disease COVID-19 is a pathogenic virus that targets mostly the human respiratory system and also other organs. SARS-CoV-2 is a new strain that has not been previously identified in humans, however there have been previous outbreaks of different versions of the beta coronavirus including severe acute respiratory syndrome (SARS-CoV1) from 2002 to 2003 and the most recent Middle East respiratory syndrome (MERS-CoV) which was first identified in 2012. All of the above have been recognised as major pathogens that are a great threat to public health and global economies. Currently, no specific treatment for SARS-CoV-2 infection has been identified; however, certain drugs have shown apparent efficacy in viral inhibition of the disease. Natural substances such as herbs and mushrooms have previously demonstrated both great antiviral and anti-inflammatory activity. Thus, the possibilities of natural substances as effective treatments against COVID-19 may seem promising. One of the potential candidates against the SARS-CoV-2 virus may be Inonotus obliquus (IO), also known as chaga mushroom. IO commonly grows in Asia, Europe and North America and is widely used as a raw material in various medical conditions. In this review, we have evaluated the most effective herbs and mushrooms, in terms of the antiviral and anti-inflammatory effects which have been assessed in laboratory conditions.
Open AccessThe Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection
The 2019 novel coronavirus, SARS-CoV-2, producing the disease COVID-19 is a pathogenic virus that targets mostly the human respiratory system and also other organs. SARS-CoV-2 is a new strain that has not been previously identified in humans, however there have been previous outbreaks of different versions of the beta coronavirus including severe acute respiratory syndrome (SARS-CoV1) from 2002 to 2003 and the most recent Middle East respiratory syndrome (MERS-CoV) which was first identified in 2012. All of the above have been recognised as major pathogens that are a great threat to public health and global economies. Currently, no specific treatment for SARS-CoV-2 infection has been identified; however, certain drugs have shown apparent efficacy in viral inhibition of the disease. Natural substances such as herbs and mushrooms have previously demonstrated both great antiviral and anti-inflammatory activity. Thus, the possibilities of natural substances as effective treatments against COVID-19 may seem promising. One of the potential candidates against the SARS-CoV-2 virus may be Inonotus obliquus (IO), also known as chaga mushroom. IO commonly grows in Asia, Europe and North America and is widely used as a raw material in various medical conditions. In this review, we have evaluated the most effective herbs and mushrooms, in terms of the antiviral and anti-inflammatory effects which have been assessed in laboratory conditions.
- 4 August 2020
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 18 (12) , 1201-1211
Resolution of coronavirus disease 2019 (COVID-19)
Coronavirus disease 2019 (COVID-19) was first detected in China in December, 2019, and declared as a pandemic by the World Health Organization (WHO) on March 11, 2020. The current management of COV...
- 4 August 2020
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 18 (12) , 1201-1211
Resolution of coronavirus disease 2019 (COVID-19)
Coronavirus disease 2019 (COVID-19) was first detected in China in December, 2019, and declared as a pandemic by the World Health Organization (WHO) on March 11, 2020. The current management of COV...
- Open Access
- 20 July 2020
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- Vol. 19, 85-S 87
COVID-19: A natural phenomena or laboratory-based origin?
The novel coronavirus, otherwise known as COVID-19 has fast become a major health concern. The current pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV‐ 2) is the third coronavirus outbreak, following severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses. Since the initial cases of a pneumonia of unknown aetiology, which was later identified as COVID-19 in Wuhan, Hubei province, China, there has been much debate and speculation regarding the origins of this novel virus. This review aims to provide an insight into the origin of SARS-CoV-2 by reflecting on genomic data gathered thus far. Identifying the origins of SARS-CoV-2 can lead to better understanding of hidden viral reservoirs that may exist and pose a threat to society as well as allow greater understanding of the mechanisms by which these viruses have successfully achieved cross species transmission. Greater knowledge in regard to this can lead to the development of strategies which can aid in preventing future outbreaks of this scale. Bangladesh Journal of Medical Science Vol.19(0) 2020 p. p. S 85-S 87
- 20 July 2020
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- Vol. 19, 85-S 87
Open AccessCOVID-19: A natural phenomena or laboratory-based origin?
The novel coronavirus, otherwise known as COVID-19 has fast become a major health concern. The current pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV‐ 2) is the third coronavirus outbreak, following severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses. Since the initial cases of a pneumonia of unknown aetiology, which was later identified as COVID-19 in Wuhan, Hubei province, China, there has been much debate and speculation regarding the origins of this novel virus. This review aims to provide an insight into the origin of SARS-CoV-2 by reflecting on genomic data gathered thus far. Identifying the origins of SARS-CoV-2 can lead to better understanding of hidden viral reservoirs that may exist and pose a threat to society as well as allow greater understanding of the mechanisms by which these viruses have successfully achieved cross species transmission. Greater knowledge in regard to this can lead to the development of strategies which can aid in preventing future outbreaks of this scale. Bangladesh Journal of Medical Science Vol.19(0) 2020 p. p. S 85-S 87
- 29 June 2020
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 34 (10) , E568-E570
Urticaria (angioedema) and COVID‐19 infection
- 29 June 2020
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 34 (10) , E568-E570
Urticaria (angioedema) and COVID‐19 infection